首页> 外文期刊>The journal for nurse practitioners: JNP >Warfarin Drug Interactions: Strategies to Minimize Adverse Drug Events
【24h】

Warfarin Drug Interactions: Strategies to Minimize Adverse Drug Events

机译:华法林药物相互作用:最小化不良药物事件的策略

获取原文
获取原文并翻译 | 示例
           

摘要

Warfarin, is an oral anticoagulant that requires international normalized ratio (INR.) mpnitoring to assess its safety and efficacy and to facilitate dosage adjustments. It is metabolized primarily by CYP2C9 and has a narrow therapeutic index. Warfarin is prone to drug interactions, given its pharmacokinetic and pharmacodynamic properties. Changes in concomitant medications can cause INR fluctuations, particularly if medications are cytochrome P450 inhibitors or inducers.The unpredictability of the extent and duration of an interaction's effect make it challenging to manage, as represented in this case report. Providers are encouraged to adopt strategies to identify potential drug interactions and minimize the risks of adverse outcomes.
机译:华法林是一种口服抗凝剂,需要国际标准化比率(INR。)监测,以评估其安全性和功效并促进剂量调整。它主要由CYP2C9代谢,具有较窄的治疗指数。鉴于华法林的药代动力学和药效学特性,它易于发生药物相互作用。伴随药物的变化会导致INR波动,特别是如果药物是细胞色素P450抑制剂或诱导剂。相互作用作用的程度和持续时间的不可预测性使其难以管理,如本病例报告所述。鼓励提供者采用策略来识别潜在的药物相互作用,并最大程度地降低不良后果的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号